Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1300.65
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 61 EP applications Geoffrey Corlett Woods has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 26, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11848634

METHOD FOR PRODUCING PROTEINS

IPC classification:
C12P 21/02, C12N 5/10, C12N 15/09
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP11848771

CELL MIGRATION MODULATOR

IPC classification:
C07K 14/745, A61P 35/04, A61P 17/02, A61P 9/10, A61K 38/36
Applicant:
Nihon University
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
EXAMINATION REQUESTED
EP12748831

METHOD OF PRODUCING RETINAL PIGMENT EPITHELIAL CELL SHEET

IPC classification:
A61K 35/44, C12N 5/10, C12N 5/071, A61P 27/02
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12755521

METHOD FOR PRODUCING GLYCOPEPTIDE HAVING SIALYL SUGAR CHAIN, SIALYL SUGAR CHAIN-ADDED AMINO ACID DERIVATIVE TO BE USED IN SAME, AND GLYCOPEPTIDE

IPC classification:
C08B 37/00, C07K 1/06
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12761423

LINE-1 HYPOMETHYLATION AS A BIOMARKER FOR EARLY-ONSET COLORECTAL CANCER

IPC classification:
G01N 33/48, C12Q 1/68
Applicant:
Baylor Research Institute
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION WITHDRAWN
EP12760610

CHANGES IN THE EXPRESSION OF MIR-200C/141 CLUSTER OF MICRORNAS AS BIOMARKERS FOR EPITHELIAL-TO-MESENCHYMAL TRANSITION IN HUMAN COLORECTAL CANCER METASTASIS

IPC classification:
C12Q 1/68
Applicant:
Baylor Research Institute
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12761497

LONG INTERSPERSED NUCLEAR ELEMENTS (LINE-1) AND ALU HYPOMETHYLATION AS BIOMARKERS FOR COLORECTAL CANCER METASTASIS

IPC classification:
G01N 33/50, C12Q 1/68
Applicant:
Baylor Research Institute
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12761204

BIOMARKERS FOR PREDICTING THE RECURRENCE OF COLORECTAL CANCER METASTASIS

IPC classification:
C12Q 1/68
Applicant:
Baylor Research Institute
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12765865

COMPOSITIONS AND METHODS TO IMMUNIZE AGAINST HEPATITIS C VIRUS

IPC classification:
A61K 39/395, A61K 39/29, C12N 5/0784, C07K 16/46, A61P 37/04, A61P 31/12
Applicant:
Baylor Research Institute
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Cabinet Plasseraud
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12765017

REGULATOR OF ANAPLASTIC STATE AND APPLICATIONS THEREFOR

IPC classification:
C12N 15/09, C12N 5/10, C12N 5/073, C12N 1/00, C07K 14/52
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12767723

REVERSING THE EFFECTS OF THE TUMOR MICROENVIRONMENT USING CHIMERIC CYTOKINE RECEPTORS

IPC classification:
C12N 5/00
Applicant:
Baylor College of Medicine
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12797146

CARBON-MONOXIDE(CO)-ASSISTED INHIBITION OF FATTY ACID AND CHOLESTEROL UPTAKE

IPC classification:
A61K 33/24, A61K 33/08, A61K 33/00, A61K 31/4525, A61K 31/366, A61K 31/36, A61K 31/02, A61P 9/10, A61P 3/06, A61P 3/04, A61P 1/16
Applicant:
Japan Science and Technology Agency
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
APPLICATION WITHDRAWN
EP12782845

PROCESS FOR PREPARING PHOSPHATE COMPOUND BEARING ISOTOPE

IPC classification:
C07H 21/02, C07H 1/02, C07B 59/00
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11848424

PROTEIN PRODUCTION METHOD

IPC classification:
C12N 15/85, C07K 16/10, C07K 16/24, C07K 16/28, C12P 21/08, C12P 21/02, C12N 5/10, C12N 15/09
Applicant:
Inter-University Research Institute Corporation Research Organization of Information and Systems
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12817890

ANTIBODY FOR DETECTING EPITHELIAL OVARIAN CANCER MARKER AND METHOD FOR DIAGNOSING EPITHELIAL OVARIAN CANCER

IPC classification:
G01N 33/574, G01N 33/573, C12P 21/08, C12N 15/09, C12N 9/10, C12N 5/10, C07K 16/40
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
The patent has been granted
EP12818196

ANTIBODY FOR DETECTING EPITHELIAL OVARIAN CANCER MARKER AND METHOD FOR DIAGNOSING EPITHELIAL OVARIAN CANCER

IPC classification:
G01N 33/574, G01N 33/573, C12P 21/08, C12N 15/09, C12N 9/10, C12N 5/10, C07K 16/40
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12820579

CELL FOR USE IN IMMUNOTHERAPY WHICH CONTAINS MODIFIED NUCLEIC ACID CONSTRUCT ENCODING WILMS TUMOR GENE PRODUCT OR FRAGMENT THEREOF, METHOD FOR PRODUCING SAID CELL, AND SAID NUCLEIC ACID CONSTRUCT

IPC classification:
A61K 39/00, C12N 15/09, C12N 5/10, C07K 14/82
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12819336

NOVEL MODIFIED PROTEIN COMPRISING TANDEM-TYPE MULTIMER OF MUTANT EXTRACELLULAR DOMAIN OF PROTEIN G

IPC classification:
C12N 15/09, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15, C07K 19/00, C07K 17/00, C07K 14/315
Applicant:
Daicel Corporation
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12803735

SOLUBLE INTEGRIN ALPHA-4 MUTANT

IPC classification:
A61K 39/395, A61K 38/00, C07K 16/28, C07K 14/71, A61P 37/06, A61P 37/00, A61P 35/04, A61P 35/00, A61P 31/18, A61P 29/00, A61P 25/00, A61P 19/02, A61P 17/00, A61P 13/12, A61P 11/00, A61P 9/10, A61P 3/10, A61P 1/04
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12825488

IgG-BINDING PEPTIDE AND METHOD FOR DETECTING AND PURIFYING IgG USING SAME

IPC classification:
G01N 33/53, G01N 30/88, C12N 15/09, C07K 19/00, C07K 17/00, C07K 7/08, C07K 1/16
Applicant:
Kagoshima University
Applicant:
Otsuka Chemical Co., Ltd.
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12826199

CONDITIONALLY REPLICATION-COMPETENT ADENOVIRUS

IPC classification:
C12Q 1/02, C12N 15/09, C12N 7/00
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12829373

ANTIBODY CAPABLE OF BINDING TO SPECIFIC REGION OF PERIOSTIN, AND METHOD FOR MEASURING PERIOSTIN USING SAME

IPC classification:
G01N 33/53, C07K 16/28
Applicant:
Saga University
Applicant:
Kurume University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12831816

PHARMACEUTICAL PRODUCT FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE

IPC classification:
A61K 35/55, A61K 35/12, A61P 25/28
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12832460

METHOD FOR TESTING ANTIBACTERIAL-DRUG SENSITIVITY OF BACTERIUM OR FUNGUS AND SYSTEM USED FOR SAME

IPC classification:
G01N 37/00, G01N 33/48, C12Q 1/18, C12M 1/34
Applicant:
Osaka University
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
The patent has been granted
EP12837508

METHOD FOR INDUCING OREXIN NEURON

IPC classification:
G01N 33/50, G01N 33/15, C12Q 1/02, C12N 5/10, C12N 5/0797, C12N 5/0793, C12N 5/0775, C12N 5/0735
Applicant:
University of Tokyo
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12838341

ANTIGEN-BINDING MOLECULE FOR PROMOTING CLEARANCE FROM PLASMA OF ANTIGEN COMPRISING SACCHARIDE CHAIN RECEPTOR-BINDING DOMAIN

IPC classification:
A61K 39/395, A61K 39/00, C12Q 1/02, C12P 21/08, C12P 21/02, C12N 15/09, C07K 16/18
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12837799

METHOD FOR PRODUCING CORNEAL ENDOTHELIAL CELL

IPC classification:
A61L 27/00, A61K 35/44, C12N 15/09, C12N 5/10, A61P 27/02
Applicant:
Keio University
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP12779704

IMPROVED SUGAR-COATED LIPOSOME COMPOSITION

IPC classification:
A61K 48/00, A61K 47/36, A61K 39/39, A61K 39/00, A61K 38/00, A61K 31/7088, A61K 9/127, C07K 14/705, A61P 35/00
Applicant:
Tokai University Educational System
Applicant:
Sapporo Medical University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12829819

PRIMER SET, METHOD FOR AMPLIFYING TARGET NUCLEIC ACID SEQUENCE USING SAME, AND METHOD FOR DETECTING MUTATED NUCLEIC ACID USING SAME

IPC classification:
C12Q 1/68, C12N 15/09
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP12845639

METHOD FOR CULTURING STEM CELL

IPC classification:
A61K 35/12, C12N 5/0735, A61P 5/38, A61P 5/24, A61P 5/14, A61P 5/06, A61P 5/00
Applicant:
Sumitomo Chemical Company Limited
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12846950

FIBROBLASTS FOR TREATMENT OF DEGENERATIVE DISC DISEASE

IPC classification:
C12N 5/00
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP13176176

Compositions with reduced dimer formation

IPC classification:
A61K 39/35, A61K 47/26, A61K 47/10, A61K 9/19
Applicant:
Circassia Limited
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12760466

DENDRITIC CELLS (DCS) TARGETING FOR TUBERCULOSIS (TB) VACCINE

IPC classification:
A61K 39/395, A61K 39/04, A61K 31/06, C12N 5/0784, C07K 16/46, C07K 16/28, A61P 37/04
Applicant:
Baylor Research Institute
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12853200

A CTC BIOMARKER ASSAY TO COMBAT BREAST CANCER BRAIN METASTASIS

IPC classification:
G01N 33/53, C12Q 1/68, A61P 35/04, A61P 35/00
Applicant:
Baylor College of Medicine
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12837264

METHOD FOR EVALUATING DRUG SENSITIVITY AND SUSCEPTIBILITY TO DISEASES BY ANALYZING GENE FOR PROTEIN CAPABLE OF BINDING TO CYCLIC-AMP-RESPONSIVE SEQUENCE

IPC classification:
C12Q 1/68, C12N 15/09
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13185830

Human immune therapies using a CD27 agonist alone or in combination with other immune modulators

IPC classification:
A61K 39/395, C07K 16/28, C07K 16/00, A61P 35/00
Applicant:
University of Southampton
Agent:
Multiple attorneys, J A Kemp
Agent:
Boult Wade Tennant Ltd
Status:
GRANT OF PATENT INTENDED
EP12852269

ANTI-HUMAN TROP-2 ANTIBODY EXHIBITING ANTITUMOR ACTIVITY IN VIVO

IPC classification:
A61K 39/395, G01N 33/53, C12P 21/08, C12N 15/09, C07K 16/30, A61P 35/00
Applicant:
LIVTECH, INC.
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12860743

EXOSOME ANALYSIS METHOD, REAGENT FOR USE IN ANALYSIS OF EXOSOME, AND EXOSOME ANALYSIS APPARATUS

IPC classification:
G01N 33/532, G01N 33/53
Applicant:
Shionogi & Co. Limited (Shionogi Seiyaku Kabushiki-gaisha)
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP13738597

PROPHYLACTIC AND THERAPEUTIC DRUG FOR AMYOTROPHIC LATERAL SCLEROSIS AND METHOD OF SCREENING THEREFOR

IPC classification:
A61K 31/192, G01N 33/50, G01N 33/15, C12Q 1/68, A61P 21/00
Applicant:
Kyoto University
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13746524

PEPMIXES TO GENERATE MULTIVIRAL CTLS WITH BROAD SPECIFICITY

IPC classification:
A01N 63/00, C12N 15/00
Applicant:
Baylor College of Medicine
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13751132

METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISM AND PROSTATE CANCER

IPC classification:
A61K 38/00, A61K 31/00
Applicant:
University of Chicago
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13758041

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER

IPC classification:
A61K 48/00, A61K 39/395, A61K 31/7105, A61P 35/00
Applicant:
National Cancer Center (Japan)
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13757952

PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE

IPC classification:
A61K 47/18, A61K 47/02, A61K 39/39, A61K 39/00, A61K 9/19, A61K 9/08, A61P 37/04, A61P 35/00
Applicant:
OncoTherapy Science Inc
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11844377

IMMUNOTHERAPY USING ALLO-NKT CELLS, CELLS FOR IMMUNOTHERAPY IN WHICH alpha CHAIN OF T-CELL RECEPTOR (TCR) GENE HAS BEEN REARRANGED TO UNIFORM V alpha-J alpha , AND BANKING OF NKT CELLS DERIVED FROM SAID CELLS

IPC classification:
C12N 5/0783, C07K 14/725, A61K 45/06, A61P 37/08, A61P 37/06, A61P 35/00, A61P 31/00, A61K 31/7028, A61K 35/14
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11872034

ANTIBODY AGAINST MUTANT alpha-ACTININ-4

IPC classification:
A61K 48/00, A61K 45/00, A61K 39/395, G01N 33/574, C12Q 1/68, C12P 21/08, C12N 15/113, C12N 15/02, C12N 5/16, C12N 5/10, C07K 16/30, C07K 16/18
Applicant:
National Cancer Center (Japan)
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12797050

FLAVIN-BINDING GLUCOSE DEHYDROGENASE, METHOD FOR MANUFACTURING FLAVIN-BINDING GLUCOSE DEHYDROGENASE, AND GLUCOSE MEASUREMENT METHOD USING SAME

IPC classification:
C12Q 1/54, C12Q 1/32, C12Q 1/00, C12N 15/09, C12N 9/04, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP12799817

ANALYSIS OF TOTAL HOMOCYSTEINE AND METHYLMALONIC ACID IN PLASMA BY LC-MS/MS FROM A PLASMA SEPARATOR DEVICE (PSD)

IPC classification:
A61B 5/15, G01N 33/49, G01N 30/72, B01L 3/00
Applicant:
Baylor Research Institute
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION WITHDRAWN
EP12872831

HUMANIZED MOUSE

IPC classification:
A01K 67/027, C12N 15/09
Applicant:
Kumamoto University
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13770378

NUCLEIC ACID MOLECULE CAPABLE OF INHIBITING EXPRESSION OF PERIOSTIN GENE, METHOD FOR INHIBITING EXPRESSION OF PERIOSTIN GENE, AND USE OF SAID NUCLEIC ACID MOLECULE

IPC classification:
A61K 48/00, A61K 31/7088, C12N 15/113, C12N 15/09, A61P 43/00, A61P 27/02
Applicant:
Kyushu University
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13782434

CELL PREPARATION CONTAINING MYOCARDIUM-COMMITTED CELL

IPC classification:
A61L 27/00, A61K 35/36, C12N 5/077, C12N 5/07, A61P 9/00
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13731594

WHOLE CELL ASSAYS AND METHODS

IPC classification:
G01N 33/574, G01N 33/50
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13812775

THERAPEUTIC AGENT FOR ANEMIA INCLUDING RENAL ANEMIA AND CANCER-INDUCED ANEMIA WHICH CONTAINS ANTI-BMP9 ANTIBODY AS ACTIVE INGREDIENT

IPC classification:
C12P 21/08, C12N 15/09, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15, C07K 16/18
Applicant:
Kyowa Hakko Kirin Co., Ltd. (Kyōwa Hakkō Kirin Kabushiki-gaisha)
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13731230

METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN

IPC classification:
A61K 31/517, A61K 31/513, A61K 31/4745, A61K 9/00, A61P 35/00
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Edward Christopher Oates, Carpmaels & Ransford LLP
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
PATENT GRANTED
EP13828037

THERAPEUTICS DISPENSING DEVICE AND METHODS OF MAKING SAME

IPC classification:
A61P 27/06
Applicant:
University of California
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11845150

E. COLI TRANSFORMANT, PRODUCTION METHOD FOR FLAVIN-BOUND GLUCOSE DEHYDROGENASE USING SAME, AND MUTANT FLAVIN-BOUND GLUCOSE DEHYDROGENASE

IPC classification:
C12P 21/02, C12N 9/04, C12N 1/21, C12N 15/09
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15151984

Tetramer of extracellular domain of PD-L1

IPC classification:
A61K 47/26, A61K 38/00, A61K 9/19, A61K 9/00, C07K 14/705
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP15152164

Grass peptides for vaccine

IPC classification:
A61K 39/36, A61K 38/16, A61K 38/04, C07K 14/415, C07K 7/08, C07K 7/06
Applicant:
Circassia Limited
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15153661

Immunogenic composition for use in vaccination against Staphylococcei

IPC classification:
A61K 39/116, A61K 39/085, C07K 16/12, A61P 31/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13184178

Single-stranded RNA molecule having nitrogen-containing alicyclic skeleton

IPC classification:
C12N 15/113
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11852281

Screening method for a compound capable of suppressing receptor tyrosine kinase-mediated pro-survival signaling in a cancer cell

IPC classification:
A61K 38/22, A61K 35/74, A61K 35/14, G01N 33/50, G01N 33/15, C12Q 1/48, C12N 15/09, C12N 1/02, A61P 35/00, A61K 48/00, A61K 39/395, A61K 31/7088, A61K 45/00
Applicant:
Nagoya University
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
PATENT GRANTED
EP11845337

FLAVIN-BOUND GLUCOSE DEHYROGENASE, PRODUCTION METHOD FOR FLAVIN-BOUND GLUCOSE DEHYROGENASE, AND YEAST TRANSFORMANT USED IN SAME

IPC classification:
C12P 21/02, C12N 9/04, C12N 1/19, C12N 15/09
Agent:
Geoffrey Corlett Woods, J A Kemp
Status:
PATENT GRANTED

Please Sign in to use this feature